Literature DB >> 16303831

Low serum thyrotropin is associated with high plasma fibrinogen.

Marcus Dörr1, Daniel M Robinson, Henri Wallaschofski, Christian Schwahn, Ulrich John, Stephan B Felix, Henry Völzke.   

Abstract

BACKGROUND: Elevated plasma fibrinogen levels are associated with an increased risk of cardiovascular events. Decreased serum TSH predicts vascular mortality, which hypothetically could be explained in part by alterations in the blood coagulation system.
OBJECTIVE: The objective of this study was to investigate the association between thyroid function and plasma fibrinogen levels in a general population.
DESIGN: The population-based Study of Health in Pomerania was performed in a previously iodine-deficient area in Germany, including 4310 subjects, aged 20-79 yr. Data for 3804 individuals without thyroid disease were analyzed. Analysis revealed an association between thyroid function status and plasma fibrinogen concentration.
RESULTS: Elevated fibrinogen levels (>3.25 g/liter) were observed in 14 subjects with increased serum TSH levels (32.6%), 973 euthyroid subjects (28.9%), 158 subjects with decreased serum TSH levels (40.7%), and six individuals with overt hyperthyroidism (54.4%). Logistic regression analysis revealed decreased serum TSH as an independent risk factor for elevated fibrinogen levels (odds ratio, 1.42; 95% confidence interval, 1.12-1.80).
CONCLUSIONS: Thyroid function is associated with plasma fibrinogen. Decreased serum TSH is an independent risk factor for elevated plasma fibrinogen levels as a possible explanation for the high cardiovascular mortality among affected subjects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16303831     DOI: 10.1210/jc.2005-1786

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Utility of plasma fibrinogen in the differential diagnosis of thyrotoxicosis.

Authors:  Jie Ma; Rui Liu; Di Wu; Wei Miao; Qian Chen; Yushu Li; Haixia Guan
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Mortality and coronary heart disease in euthyroid patients.

Authors:  David Pereg; Amir Tirosh; Avishay Elis; Yoram Neuman; Morris Mosseri; David Segev; Michael Lishner; Doron Hermoni
Journal:  Am J Med       Date:  2012-05-16       Impact factor: 4.965

Review 3.  Cardiovascular involvement in patients with different causes of hyperthyroidism.

Authors:  Bernadette Biondi; George J Kahaly
Journal:  Nat Rev Endocrinol       Date:  2010-06-29       Impact factor: 43.330

4.  Hyperthyroidism is associated with shortened APTT and increased fibrinogen values in a general population of unselected outpatients.

Authors:  Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Gian Luca Salvagno; Gian Cesare Guidi; Emmanuel J Favaloro
Journal:  J Thromb Thrombolysis       Date:  2008-09-12       Impact factor: 2.300

5.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; İrfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2009-10-27       Impact factor: 3.633

Review 6.  Thyroid hormones and cardiovascular disease.

Authors:  Avais Jabbar; Alessandro Pingitore; Simon H S Pearce; Azfar Zaman; Giorgio Iervasi; Salman Razvi
Journal:  Nat Rev Cardiol       Date:  2016-11-04       Impact factor: 32.419

7.  Hyperthyroidism: A rare cause of pulmonary embolism: Report of two cases.

Authors:  Sonia Grine; Nadia Charfi; Mahdi Kamoun; Fatma Mnif; Basma Ben Naceur; Nabila Rekik; Mouna Mnif; Mohamed Abid
Journal:  Indian J Endocrinol Metab       Date:  2013-11

8.  The association of thyroid stimulation hormone levels with incident ischemic heart disease, incident stroke, and all-cause mortality.

Authors:  Line Tang Møllehave; Tea Skaaby; Allan Linneberg; Nils Knudsen; Torben Jørgensen; Betina Heinsbæk Thuesen
Journal:  Endocrine       Date:  2020-02-10       Impact factor: 3.633

9.  Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study.

Authors:  Massimo Giusti; Lorenzo Mortara; Roberta Degrandi; Francesca Cecoli; Michele Mussap; Guido Rodriguez; Diego Ferone; Francesco Minuto
Journal:  Thyroid Res       Date:  2008-09-29

10.  Antiphospholipid Antibody Syndrome Associated with Graves' Disease Presenting As Inferior Vena Cava Thrombosis with Bilateral Lower Limb DVT.

Authors:  Ankur Jain
Journal:  Clin Med Insights Case Rep       Date:  2014-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.